SCHEMBL9788544

SCHEMBL9788544

Oc1ccc(-n2cnc3ccccc32)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 1.00
HTT P42858 2/20 0.72
P4HB P07237 1/20 0.53
SRC P12931 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7987340 0.98 FGFR1 (0.96) FGFR1HTTP4HBSRC
SCHEMBL30402227 0.90 HTT (0.88) FGFR1HTT
SCHEMBL3419279 0.90 HTT (0.88) FGFR1HTT
SCHEMBL2531256 0.85 HTT (0.78) FGFR1HTT
Benzene SCHEMBL14876970 0.84 HTT (1.00) FGFR1HTT
SCHEMBL157265 0.84 HTT (1.00) FGFR1HTT
SCHEMBL5246440 0.83 HTT (0.75) FGFR1HTT
Iodide SCHEMBL30645138 0.82 HTT (0.96) FGFR1HTT
SCHEMBL4891428 0.82 HTT (0.96) FGFR1HTT
SCHEMBL467858 0.82 HTT (0.96) FGFR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112961102-B Metal complex and electron transport material using the same 大电株式会社 2024-03-12 CN disclosed
CN-109689665-B Metal complex and electron transport material using the same 大电株式会社 2021-10-01 CN disclosed
CN-112961102-A Metal complex and electron transport material using the same 大电株式会社 2021-06-15 CN disclosed
CN-109689665-A Metal complex and electron transport material using the same 大电株式会社 2019-04-26 CN disclosed
EP-2565185-A1 [5,6]HETEROCYCLIC COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-03-06 EP disclosed
US-20130029964-A1 [5, 6] HETEROCYCLIC COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-31 US disclosed
US-5043266-A Immunoassay, reaction between a dihydrophthalazinedione (luminol) and hydrogen peroxide, peroxidase enzyme NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1991-08-27 US disclosed
EP-0296752-A1 Enhanced chemiluminescent reaction and diagnostic assay BTG INTERNATIONAL LIMITED (GB) 1988-12-28 EP disclosed
US-4714762-A Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof WARNER-LAMBERT COMPANY (US) 1987-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029964-A1 [5, 6] HETEROCYCLIC COMPOUND BMP2, BMP4, SOST FGFR1 128/4885HTT 4682/4885P4HB 2589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.